PRINCETON, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Nitazoxanide Tablets, 500 mg. ANI’s Nitazoxanide ...

PRINCETON, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Nitazoxanide Tablets, 500 mg. ANI’s Nitazoxanide Tablets ...

ANI Pharmaceuticals (ANIP) announced the launch of Nitazoxanide Tablets, 500 mg. ANI’s Nitazoxanide Tablets are the generic version of the ...

ANI Pharmaceuticals stock opened at $58.46 on Monday. The stock has a market cap of $1.23 billion, a PE ratio of -106.29 and a beta of 0.74. ANI Pharmaceuticals has a fifty-two week low of $52.50 ...

ANI Pharmaceuticals is introducing nitazoxanide tablets, 500 mg, which is the generic of Alinia. The medication is used to treat diarrhea caused by certain parasites. "The market launch of ...

4 analysts have expressed a variety of opinions on ANI Pharmaceuticals ANIP over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table summarizes their ...

ANI Pharmaceuticals Stock Down 0.1 % Shares of ANIP opened at $64.26 on Friday. The firm has a market cap of $1.40 billion, a P/E ratio of -116.84 and a beta of 0.63. ANI Pharmaceuticals, Inc. has ...

BAUDETTE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that it has completed the buyout of its 3.125% perpetual royalty ...

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q4 2024 Earnings Call Transcript February 28, 2025 ANI Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $1.63, expectations were $1.41.

(MENAFN- GlobeNewsWire - Nasdaq) PRINCETON, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Nitazoxanide ...